ANN ARBOR, MICH. (PRWEB) SEPTEMBER 06, 2018
Akadeum Life Sciences today announced it has appointed George Dunbar to its Board of Directors. Dunbar has spent his career as an executive and leader of numerous biotech companies.
He most recently served as president and CEO of ISTO Biologics, a private cell therapy and biologics company acquired by Thompson Street Capital in St. Louis, MO. Prior to ISTO, he was a Venture Partner with Arboretum Ventures, a leading life science venture capital firm.
Dunbar is joining Akadeum to work with the company on its current focused strategy of commercializing and growing its microbubble-based cell separation kits. “I’m excited to be joining Akadeum at a time when their initial products are being prepared for launch. The market has needed this type of radical simplification of next gen separation technologies,” said Dunbar.
Read more here.